Log In
Print this Print this

MIN-301 (formerly NRG-101)

  Manage Alerts
Collapse Summary General Information
Company Minerva Neurosciences Inc.
DescriptionNeuregulin 1 (NRG1) peptide
Molecular Target Neuregulin 1 (NRG1) (HRG1)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today